Key facts
- This page summarizes Timothy Schmid's Form 4 filing for JOHNSON & JOHNSON (JNJ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Feb 2026, 17:20.
Timothy Schmid - 20 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)
- Reporting relationship
- EVP, WW Chair, MedTech
- Issuer ticker
- JNJ
- Reported as of
- 20 Feb 2026
- Net transaction value
- -$324,763
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2026, 17:20:21 UTC
- Prior SEC filing
- 18 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Timothy Schmid filed Form 4 for JOHNSON & JOHNSON (JNJ) on 23 Feb 2026.
Change
- Previous filing in this sequence was filed on 18 Feb 2026.
- Current net transaction value: -$324,763.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001998491
Primary reporting owner
Schmid Timothy
- Relationship
- EVP, WW Chair, MedTech
- Address
- ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK
- Signature
- /s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid
- Signature date
- 23 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JNJ
transaction
Common Stock
Sale
- Transaction value
- $324,763
- Shares
- -1,322
- Change %
- -4.9%
- Price
- $245.66
- Shares after
- 25,447
- Date
- 20 Feb 2026
- Ownership
- Direct
JNJ
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 46
- Date
- 20 Feb 2026
- Ownership
- By ESOP
- Footnotes
- F1
JNJ
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 745
- Date
- 20 Feb 2026
- Ownership
- By 401k
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
Footnote F2
Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).